Dai Yanmei, Zhao Sheng, Wu Qiong, Zhang Jin, Zeng Xu, Jiang Huijie
Department of Radiology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, People's Republic of China.
Department of Radiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, People's Republic of China.
J Hepatocell Carcinoma. 2025 Jul 29;12:1647-1659. doi: 10.2147/JHC.S525920. eCollection 2025.
This study aimed to construct a novel retreatment scoring system to screen patients with hepatocellular carcinoma (HCC) who could benefit further after transarterial chemoembolization (TACE).
310 patients with HCC were retrospectively recruited from three hospitals. The training and validation cohort were randomly selected from Center 1, and two external testing cohorts comprised from Center 2 and Center 3, respectively. Deep learning score and handcrafted radiomics signatures were constructed from the pretreatment arterial-phase and venous-phase CT images. The optimal features were screened using SelectKBest and LASSO regression. The AUC of the optimal combined model, consisting of HBsAg, five radiomics features, and DLscore, was 0.97, 0.89, 0.76, and 0.84 in the four cohorts, respectively. The optimal model was well calibrated. The prediction performance was assessed with respect to receiver operating characteristics, calibration, and decision curve analysis. Kaplan-Meier survival curves based on the scoring system were used to estimate the overall survival (OS).
The optimal combined model consisted of HBsAg, 5 radiomics signatures, and DLscore, which AUC in four cohorts was 0.97, 0.89, 0.76, and 0.84, respectively, with good calibration. Decision curve analysis confirmed that the combined model was clinically useful. After Cox regression analysis of these characteristics, the scoring system (HBsAg-Radscore-DLscore, HRD) was significantly associated with OS in patients with HCC, and was superior to the traditional ART score and ABCR score between high and low-risk patients.
Deep learning and radiomics had good performance in predicting the OS of patients with HCC treated with repeated TACE. The HRD score is a potentially valuable and intelligent prognostic scoring system better than the traditional score.
本研究旨在构建一种新型再治疗评分系统,以筛选出经动脉化疗栓塞术(TACE)后可能进一步获益的肝细胞癌(HCC)患者。
回顾性招募了来自三家医院的310例HCC患者。训练和验证队列从中心1随机选取,两个外部测试队列分别由中心2和中心3组成。从治疗前动脉期和静脉期CT图像构建深度学习评分和手工制作的放射组学特征。使用SelectKBest和LASSO回归筛选最佳特征。由HBsAg、五个放射组学特征和DLscore组成的最佳组合模型在四个队列中的AUC分别为0.97、0.89、0.76和0.84。最佳模型校准良好。根据受试者操作特征、校准和决策曲线分析评估预测性能。基于评分系统的Kaplan-Meier生存曲线用于估计总生存期(OS)。
最佳组合模型由HBsAg、5个放射组学特征和DLscore组成,其在四个队列中的AUC分别为0.97、0.89、0.76和0.84,校准良好。决策曲线分析证实该组合模型具有临床实用性。对这些特征进行Cox回归分析后,评分系统(HBsAg-Radscore-DLscore,HRD)与HCC患者的OS显著相关,且在高风险和低风险患者中优于传统的ART评分和ABCR评分。
深度学习和放射组学在预测接受重复TACE治疗的HCC患者的OS方面表现良好。HRD评分是一种比传统评分更具潜在价值和智能的预后评分系统。